Evidence Hub

Uremic pericarditis in a not-so-terminal chronic kidney disease

Coulibaly Z, Ngatchou N, Tataw J

Revue medicale suisse, 2024

Abstract

A 90-year-old patient with chronic kidney disease (stage G4) was diagnosed with pneumonia and congestive heart failure. Despite treatment with levofloxacin and furosemide, his condition deteriorated. A CT scan of the chest revealed pericardial effusion, leading to the suspicion of uremic pericarditis. Daily hemodialysis was started, resulting in significant clinical and biological improvement. Uremic pericarditis due to accumulation of uremic toxins resulting in pericardial effusion is common in end-stage renal disease. Diagnosis is guided by clinical and paraclinical findings and a high index of suspicion. Early recognition and treatment remain critical to prevent complications even in pre-end stage renal disease.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free